<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Stud Health Technol Inform</journal-id><journal-id journal-id-type="iso-abbrev">Stud Health Technol Inform</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Studies in health technology and informatics</journal-title></journal-title-group><issn pub-type="ppub">0926-9630</issn><issn pub-type="epub">1879-8365</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10128894</article-id><article-id pub-id-type="pmcid-ver">PMC10128894.1</article-id><article-id pub-id-type="pmcaid">10128894</article-id><article-id pub-id-type="pmcaiid">10128894</article-id><article-id pub-id-type="manuscript-id">NIHMS1890822</article-id><article-id pub-id-type="pmid">35673054</article-id><article-id pub-id-type="doi">10.3233/SHTI220115</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1890822</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1890822</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Role of Informatics in Implementing Guidelines for Chronic Opioid Therapy Risk Assessment in Primary Care: A Narrative Review Informed by the Socio-Technical Model</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mishra</surname><given-names initials="M">Meenakshi</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pickett</surname><given-names initials="M">Mary</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Weiskopf</surname><given-names initials="NG">Nicole G.</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, OR, USA</aff><aff id="A2"><label>b</label>Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR, USA</aff><author-notes><corresp id="CR1"><bold>Address for correspondence:</bold> Meenakshi Mishra - <email>mishram@ohsu.edu</email>.</corresp></author-notes><pub-date pub-type="ppub"><day>06</day><month>6</month><year>2022</year></pub-date><volume>290</volume><issue-id pub-id-type="pmc-issue-id">434218</issue-id><fpage>447</fpage><lpage>451</lpage><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>04</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>25</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>25</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 11:25:31.053"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This article is published online with Open Access by IOS Press and distributed under the terms of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1890822.pdf"/><abstract id="ABS1"><p id="P1">Approximately 2 million Americans live with opioid use disorder (OUD), most of whom also have chronic pain. The economic burden of chronic pain and prescription opioid misuse runs into billions of dollars. Patients on prescription opioids for chronic non-cancer pain (CNCP) are at increased risk for OUD and overdose. By adhering to the Center for Disease Control and Prevention (CDC) opioid prescribing guidelines, primary care providers (PCPs) have the potential to improve patient outcomes. But numerous provider, patient, and practice-specific factors challenge adherence to guidelines in primary care. Many of the barriers may be mediated by informatics interventions, but gaps in knowledge and unmet needs exist. This narrative review examines the risk assessment and harm reduction process in a socio-technical context to highlight the gaps in knowledge and unmet needs that can be mediated through informatics intervention.</p></abstract><kwd-group><kwd>Practice guidelines</kwd><kwd>implementation science</kwd><kwd>socio-technical context</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P2">Approximately 16 million people worldwide and 2 million Americans live with OUD, which is defined as &#8220;a problematic pattern of opioid use leading to clinically significant impairment or distress.&#8221; [<xref rid="R1" ref-type="bibr">1</xref>&#8211;<xref rid="R3" ref-type="bibr">3</xref>] OUD is associated with considerable morbidity and mortality, with individuals experiencing OUD at ten times higher risk for mortality than the general population.[<xref rid="R4" ref-type="bibr">4</xref>] In 2019, prescription opioids were involved in approximately 20% of the death from a drug overdose in the U.S., contributing significantly to the nation&#8217;s opioid crisis. The cost of reduced quality of life from OUD and lost life due to fatal overdose was estimated to be close to 1.02 trillion dollars in 2017.[<xref rid="R5" ref-type="bibr">5</xref>]</p><p id="P3">The risk of developing OUD is especially high for patients experiencing chronic pain. Roughly 21 to 29 percent of patients prescribed opioids for chronic non-cancer pain misuse them, and between 8 and 12 percent develop OUD.[<xref rid="R6" ref-type="bibr">6</xref>] Primary care providers (PCPs) manage most chronic pain patients and prescribe about half of all prescription opioids.[<xref rid="R7" ref-type="bibr">7</xref>] Managing a complex and diverse patient population on chronic opioid therapy (COT) for non-cancer pain requires a balancing act of treating pain and preventing addiction and overdose. To provide clinicians with guidance in caring for this complex population and improve patient outcomes, the CDC has developed a set of safe opioid prescribing guidelines for chronic non-cancer pain.[<xref rid="R8" ref-type="bibr">8</xref>] Implementation of these guidelines has been challenging, and adherence by PCPs is low.[<xref rid="R9" ref-type="bibr">9</xref>; <xref rid="R10" ref-type="bibr">10</xref>] While barriers and facilitators to guideline adherence have been well studied, the challenges of recommended risk assessment and harm reduction tasks in a complex patient population is less understood and greatly underappreciated. PCPs integrate disparate data to assess their patient&#8217;s risk from opioid pain relievers which can be a source of considerable cognitive burden for a busy PCP. In fact the increased burden of managing CNCP patients on LTOP deters some providers from accepting new patients in their practice thus limiting access to primary care for this vulnerable population.[<xref rid="R11" ref-type="bibr">11</xref>].</p><p id="P4">Informatics technology and methods have the potential to decrease provider burden, increase guideline adherence, and, ultimately, improve patient outcomes. A comprehensive understanding of risk-relevant information and an assessment of knowledge and information gaps is warranted to identify ideal points and methods for effective informatics solutions.</p></sec><sec id="S2"><title>Literature Search and Framework Selection</title><p id="P5">We used a systems approach to understand and illustrate opioid prescribing and risk assessment for chronic non-cancer pain in primary care. The key risk assessment components mentioned in the CDC chronic opioid therapy risk assessment guidelines were identified and used as a guide to conduct a narrative literature review.[<xref rid="R12" ref-type="bibr">12</xref>] We searched PUBMED and SCOPUS for literature on Long Term Opioid Therapy (LTOT) for CNCP in primary care and challenges to guideline adherence. Constructs from the socio-technical model for health information technology (ST-HIT), Cabana, and Promoting Action on Research Implementation in Health Services (PARIHS) frameworks were used to explore knowledge and information gaps.[<xref rid="R13" ref-type="bibr">13</xref>&#8211;<xref rid="R15" ref-type="bibr">15</xref>] The socio-technical model is presented in <xref rid="F1" ref-type="fig">Figure 1</xref>, and the summary of findings in <xref rid="T1" ref-type="table">Table 1</xref>.</p></sec><sec id="S3"><title>Results</title><sec id="S4"><title>A Socio-Technical Model of Opioid Prescriptions in Primary Care</title><p id="P6">Nearly 20% of the visits in primary care involve three or more chronic conditions, with pain being one of the most common reasons for visits. <xref rid="F1" ref-type="fig">Figure 1</xref> is a conceptual model of opioid prescribing for chronic non-cancer pain in primary care. It illustrates the interplays between various social and technical components when assessing risk from opioid pain relievers for chronic non-cancer pain. Chronic pain is defined as pain lasting &gt;90 days or beyond the time of normal tissue healing. A PCP, when considering opioid medication for chronic pain, needs to contextualize the evidence-based guidelines with patient-specific data to make evidence-based, patient-centered decisions.</p><sec id="S5"><title>Intended Workflow and Process</title><p id="P7">A multi-faceted risk assessment process involves questioning the patient and reviewing patients&#8217; medical history in the electronic health record (EHR) to identify risk factors for adverse outcomes, including misuse, OUD, and overdose, from prescription opioids. Specifically, a prescriber should look for a history of overdose, present or past substance use disorder, and the presence of mental health conditions. A high total dose of opioids and concurrent benzodiazepine use increase the risk for overdose. Patients&#8217; pharmacy dispense history reported in the state-run prescription drug monitoring program (PDMP) database should also be reviewed. PCPs check the PDMP database to confirm the total milligram morphine equivalent (MME) opioid dose and absence of drug-seeking behaviors like receipt of prescription opioids from multiple providers and pharmacies. Also, urine drug tests and validated risk assessment tools are recommended to screen for opioid misuse.</p></sec></sec></sec><sec id="S6"><title>Discussion</title><p id="P8">Barriers to implementing CDC guidelines exist at many levels. Knowledge and information gaps are major obstacles besides organizational structure, culture, and policies. Informatics interventions hold promise to bridge knowledge and information gaps. Educational and training tools for PCPs can improve guideline application in practice. Interoperable information systems and well-designed human-computer interfaces can facilitate risk assessment tasks at the point of care. Patient registries and EHR dashboards can be used to improve cross-team communication and workflow. However, many risk assessment activities and associated diagnoses carry a considerable social stigma. Adoption of destigmatizing vocabularies and tools that enhance patient-provider communication and trust are needed. The Risk factors in CNCP patients on LTOT are dynamic. They can change with &#8220;disease progression, tolerance, changes in pain quality, mental health, comorbidities, other drug therapies or drug interactions, and changes in the patient&#8217;s lifestyle.&#8221;[<xref rid="R51" ref-type="bibr">51</xref>] When data from the screening tool is enhanced with the EHR data, PCPs can better differentiate the low-risk and high-risk populations.[<xref rid="R52" ref-type="bibr">52</xref>&#8211;<xref rid="R54" ref-type="bibr">54</xref>] There is a caveat to this though, the data in the EHR should be of good quality. There is a need to identify a minimum set of data that inform patients&#8217; risk from prescription opioids and improve its documentation in the EHR, using standard terminologies and vocabularies.</p><p id="P9">Furthermore, the impact of risk assessment on patient outcomes is not well understood. Improving data quality of patient outcomes, such as function, quality of life, misuse, OUD, and death, can better inform future policies and guidelines.</p></sec><sec id="S7"><title>Conclusion</title><p id="P10">Informatics interventions can address the socio-technical challenges to assessing risk in patients on LTOT for CNCP. Improving the data quality of patient-specific risk factors and outcomes is critical for enhancing practice and strengthening evidence.</p></sec></body><back><ack id="S8"><title>acknowledgement</title><p id="P11">This work was funded by National Library of Medicine Award# T15LM007088</p></ack><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chang</surname><given-names>HY</given-names></name>, <name name-style="western"><surname>Kharrazi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bodycombe</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Weiner</surname><given-names>JP</given-names></name>, and <name name-style="western"><surname>Alexander</surname><given-names>GC</given-names></name>, <article-title>Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study</article-title>, <source>BMC medicine</source><volume>16</volume> (<year>2018</year>), <fpage>69</fpage>.<pub-id pub-id-type="pmid">29764482</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12916-018-1058-y</pub-id><pub-id pub-id-type="pmcid">PMC5954462</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hser</surname><given-names>Y-I</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Saxon</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Miotto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>DS</given-names></name>, and <name name-style="western"><surname>Huang</surname><given-names>D</given-names></name>, <article-title>Chronic pain among patients with opioid use disorder: Results from electronic health records data</article-title>, <source>J Subst Abuse Treat</source><volume>77</volume> (<year>2017</year>), <fpage>26</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="pmid">28476267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsat.2017.03.006</pub-id><pub-id pub-id-type="pmcid">PMC5424616</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="book"><source>Diagnostic and statistical manual of mental disorders : DSM-5</source>, <edition>Fifth edition</edition>. <publisher-loc>Arlington</publisher-loc>, <publisher-name>VA : American Psychiatric Association</publisher-name>, [<year>2013</year>] <comment>&#169;2013</comment>, <fpage>2013</fpage>.</mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hser</surname><given-names>Y-I</given-names></name>, <name name-style="western"><surname>Mooney</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Saxon</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Miotto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>D</given-names></name>, and <name name-style="western"><surname>Huang</surname><given-names>D</given-names></name>, <article-title>High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System</article-title>, <source>J Addict Med</source><volume>11</volume> (<year>2017</year>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000000312</pub-id><pub-id pub-id-type="pmcid">PMC5930020</pub-id><pub-id pub-id-type="pmid">28426439</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Florence</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>F</given-names></name>, and <name name-style="western"><surname>Rice</surname><given-names>K</given-names></name>, <article-title>The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017</article-title>, <source>Drug Alcohol Depend</source><volume>218</volume> (<year>2021</year>), <fpage>108350</fpage>.<pub-id pub-id-type="pmid">33121867</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2020.108350</pub-id><pub-id pub-id-type="pmcid">PMC8091480</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vowles</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>McEntee</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Julnes</surname><given-names>PS</given-names></name>, <name name-style="western"><surname>Frohe</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ney</surname><given-names>JP</given-names></name>, and <name name-style="western"><surname>van der Goes</surname><given-names>DN</given-names></name>, <article-title>Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis</article-title>, <source>Pain</source><volume>156</volume> (<year>2015</year>), <fpage>569</fpage>&#8211;<lpage>576</lpage>.<pub-id pub-id-type="pmid">25785523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.j.pain.0000460357.01998.f1</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Levy</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Paulozzi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Mack</surname><given-names>KA</given-names></name>, and <name name-style="western"><surname>Jones</surname><given-names>CM</given-names></name>, <article-title>Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007&#8211;2012</article-title>, <source>American Journal of Preventive Medicine</source><volume>49</volume> (<year>2015</year>), <fpage>409</fpage>&#8211;<lpage>413</lpage>.<pub-id pub-id-type="pmid">25896191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2015.02.020</pub-id><pub-id pub-id-type="pmcid">PMC6034509</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Haegerich</surname><given-names>TM</given-names></name>, and <name name-style="western"><surname>Chou</surname><given-names>R</given-names></name>, <article-title>CDC Guideline for Prescribing Opioids for Chronic Pain&#8212;United States, 2016</article-title>, <source>JAMA</source><volume>315</volume> (<year>2016</year>), <fpage>1624</fpage>&#8211;<lpage>1645</lpage>.<pub-id pub-id-type="pmid">26977696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2016.1464</pub-id><pub-id pub-id-type="pmcid">PMC6390846</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kroenke</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Alford</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Argoff</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Canlas</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Covington</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Frank</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Haake</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Hanling</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hooten</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Kertesz</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Kravitz</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Krebs</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Stanos</surname><given-names>SP</given-names><suffix>Jr.</suffix></name>, and <name name-style="western"><surname>Sullivan</surname><given-names>M</given-names></name>, <article-title>Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report</article-title>, <source>Pain Medicine</source><volume>20</volume> (<year>2019</year>), <fpage>724</fpage>&#8211;<lpage>735</lpage>.<pub-id pub-id-type="pmid">30690556</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pny307</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hossain</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Asamoah-Boaheng</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Badejo</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Buckley</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Busse</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Corace</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>LK</given-names></name>, <name name-style="western"><surname>Flusk</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garcia</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Iorio</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lavoie</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Poulin</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Skidmore</surname><given-names>B</given-names></name>, and <name name-style="western"><surname>Rash</surname><given-names>JA</given-names></name>, <article-title>Prescriber adherence to guidelines for chronic noncancer pain management with opioids: Systematic review and meta-analysis</article-title>, <source>Health Psychol</source><volume>39</volume> (<year>2020</year>), <fpage>430</fpage>&#8211;<lpage>451</lpage>.<pub-id pub-id-type="pmid">31999179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/hea0000830</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lagisetty</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Healy</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Garpestad</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jannausch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Tipirneni</surname><given-names>R</given-names></name>, and <name name-style="western"><surname>Bohnert</surname><given-names>ASB</given-names></name>, <article-title>Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids</article-title>, <source>JAMA Netw Open</source><volume>2</volume> (<year>2019</year>), <fpage>e196928</fpage>.<pub-id pub-id-type="pmid">31298712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2019.6928</pub-id><pub-id pub-id-type="pmcid">PMC6628590</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Green</surname><given-names>BN</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>CD</given-names></name>, and <name name-style="western"><surname>Adams</surname><given-names>A</given-names></name>, <article-title>Writing narrative literature reviews for peer-reviewed journals: secrets of the trade</article-title>, <source>Journal of Chiropractic Medicine</source><volume>5</volume> (<year>2006</year>), <fpage>101</fpage>&#8211;<lpage>117</lpage>.<pub-id pub-id-type="pmid">19674681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0899-3467(07)60142-6</pub-id><pub-id pub-id-type="pmcid">PMC2647067</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Cabana</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Rand</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Powe</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Abboud</surname><given-names>PA</given-names></name>, and <name name-style="western"><surname>Rubin</surname><given-names>HR</given-names></name>, <article-title>Why don&#8217;t physicians follow clinical practice guidelines? A framework for improvement</article-title>, <source>JAMA</source><volume>282</volume> (<year>1999</year>), <fpage>1458</fpage>&#8211;<lpage>1465</lpage>.<pub-id pub-id-type="pmid">10535437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.282.15.1458</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kitson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Harvey</surname><given-names>G</given-names></name>, and <name name-style="western"><surname>McCormack</surname><given-names>B</given-names></name>, <article-title>Enabling the implementation of evidence based practice: a conceptual framework</article-title>, <source>Quality in Health Care</source><volume>7</volume> (<year>1998</year>), <fpage>149</fpage>.<pub-id pub-id-type="pmid">10185141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/qshc.7.3.149</pub-id><pub-id pub-id-type="pmcid">PMC2483604</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sittig</surname><given-names>DF</given-names></name> and <name name-style="western"><surname>Singh</surname><given-names>H</given-names></name>, <article-title>A new sociotechnical model for studying health information technology in complex adaptive healthcare systems</article-title>, <source>Quality &amp; safety in health care</source><volume>19 Suppl 3</volume> (<year>2010</year>), <fpage>i68</fpage>&#8211;<lpage>i74</lpage>.<pub-id pub-id-type="pmid">20959322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/qshc.2010.042085</pub-id><pub-id pub-id-type="pmcid">PMC3120130</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dowell</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Haegerich</surname><given-names>TM</given-names></name>, and <name name-style="western"><surname>Chou</surname><given-names>R</given-names></name>, <article-title>CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016</article-title>, <source>MMWR Recomm Rep</source><volume>65</volume> (<year>2016</year>), <fpage>1</fpage>&#8211;<lpage>49</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.rr6501e1</pub-id><pub-id pub-id-type="pmid">26987082</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Carrell</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Cronkite</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Saunders</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gross</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Masters</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Hylan</surname><given-names>TR</given-names></name>, and <name name-style="western"><surname>Von Korff</surname><given-names>M</given-names></name>, <article-title>Using natural language processing to identify problem usage of prescription opioids</article-title>, <source>Int J Med Inform</source><volume>84</volume> (<year>2015</year>), <fpage>1057</fpage>&#8211;<lpage>1064</lpage>.<pub-id pub-id-type="pmid">26456569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijmedinf.2015.09.002</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Porucznik</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Rolfs</surname><given-names>RT</given-names></name>, and <name name-style="western"><surname>Sauer</surname><given-names>BC</given-names></name>, <article-title>Opioid prescribing knowledge and practices: provider survey following promulgation of guidelines-Utah, 2011</article-title>, <source>J Opioid Manag</source><volume>9</volume> (<year>2013</year>), <fpage>217</fpage>&#8211;<lpage>224</lpage>.<pub-id pub-id-type="pmid">23771571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2013.0162</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Meltzer</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Rybin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Meshesha</surname><given-names>LZ</given-names></name>, <name name-style="western"><surname>Saitz</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Samet</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Rubens</surname><given-names>SL</given-names></name>, and <name name-style="western"><surname>Liebschutz</surname><given-names>JM</given-names></name>, <article-title>Aberrant drug-related behaviors: unsystematic documentation does not identify prescription drug use disorder</article-title>, <source>Pain Med</source><volume>13</volume> (<year>2012</year>), <fpage>1436</fpage>&#8211;<lpage>1443</lpage>.<pub-id pub-id-type="pmid">23057631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1526-4637.2012.01497.x</pub-id><pub-id pub-id-type="pmcid">PMC3501607</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huang</surname><given-names>KTL</given-names></name>, <name name-style="western"><surname>Blazey-Martin</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Chandler</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wurcel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gillis</surname><given-names>J</given-names></name>, and <name name-style="western"><surname>Tishler</surname><given-names>J</given-names></name>, <article-title>A multicomponent intervention to improve adherence to opioid prescribing and monitoring guidelines in primary care</article-title>, <source>J Opioid Manag</source><volume>15</volume> (<year>2019</year>), <fpage>445</fpage>&#8211;<lpage>453</lpage>.<pub-id pub-id-type="pmid">31850506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2019.0535</pub-id><pub-id pub-id-type="pmcid">PMC7787190</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Patchett</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Grover</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kresin</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bryan</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nordrum</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Buras</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pierce</surname><given-names>S</given-names></name>, and <name name-style="western"><surname>McDaniel</surname><given-names>K</given-names></name>, <article-title>The benefits of a standardized approach to opioid prescribing</article-title>, <source>J Fam Pract</source><volume>68</volume> (<year>2019</year>), <fpage>E1</fpage>&#8211;<lpage>e7</lpage>.<pub-id pub-id-type="pmid">31381628</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Downes</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Klepser</surname><given-names>DG</given-names></name>, <name name-style="western"><surname>Foster</surname><given-names>J</given-names></name>, and <name name-style="western"><surname>Nelson</surname><given-names>M</given-names></name>, <article-title>Development of a standardized approach for managing opioids in adults with chronic noncancer pain</article-title>, <source>Am J Health Syst Pharm</source><volume>75</volume> (<year>2018</year>), <fpage>321</fpage>&#8211;<lpage>326</lpage>.<pub-id pub-id-type="pmid">29472515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2146/ajhp161012</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shahi</surname><given-names>N</given-names></name> and <name name-style="western"><surname>Patchett-Marble</surname><given-names>R</given-names></name>, <article-title>Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care-The HARMS Program: A retrospective chart review of 77 patients</article-title>, <source>J Opioid Manag</source><volume>16</volume> (<year>2020</year>), <fpage>277</fpage>&#8211;<lpage>282</lpage>.<pub-id pub-id-type="pmid">32885835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2020.0581</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Winstanley</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Mashni</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schnee</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Penm</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Boone</surname><given-names>J</given-names></name>, <name name-style="western"><surname>McNamee</surname><given-names>C</given-names></name>, and <name name-style="western"><surname>MacKinnon</surname><given-names>NJ</given-names></name>, <article-title>Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing</article-title>, <source>Drug Alcohol Depend</source><volume>188</volume> (<year>2018</year>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2018.03.036</pub-id><pub-id pub-id-type="pmcid">PMC6528173</pub-id><pub-id pub-id-type="pmid">29778769</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Quanbeck</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>A</surname><given-names>EZ</given-names></name>, <name name-style="western"><surname>R</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Robinson</surname><given-names>JM</given-names></name>, and <name name-style="western"><surname>Jacobson</surname><given-names>N</given-names></name>, <article-title>Systems consultation: protocol for a novel implementation strategy designed to promote evidence-based practice in primary care</article-title>, <source>Health research policy and systems</source><volume>14</volume> (<year>2016</year>), <fpage>8</fpage>.<pub-id pub-id-type="pmid">26818455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12961-016-0079-2</pub-id><pub-id pub-id-type="pmcid">PMC4729135</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schectman</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Schroth</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Verme</surname><given-names>D</given-names></name>, and <name name-style="western"><surname>Voss</surname><given-names>JD</given-names></name>, <article-title>Randomized controlled trial of education and feedback for implementation of guidelines for acute low back pain</article-title>, <source>J Gen Intern Med</source><volume>18</volume> (<year>2003</year>), <fpage>773</fpage>&#8211;<lpage>780</lpage>.<pub-id pub-id-type="pmid">14521638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1525-1497.2003.10205.x</pub-id><pub-id pub-id-type="pmcid">PMC1494929</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Barth</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Adams</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Nikitin</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wooten</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Qureshi</surname><given-names>ZP</given-names></name>, and <name name-style="western"><surname>Larson</surname><given-names>MJ</given-names></name>, <article-title>Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians</article-title>, <source>The Journal of continuing education in the health professions</source><volume>37</volume> (<year>2017</year>), <fpage>98</fpage>&#8211;<lpage>105</lpage>.<pub-id pub-id-type="pmid">28562498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/CEH.0000000000000149</pub-id><pub-id pub-id-type="pmcid">PMC5521811</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Poon</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Greenwood-Ericksen</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Gish</surname><given-names>RE</given-names></name>, <name name-style="western"><surname>Neri</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Takhar</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Weiner</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Schuur</surname><given-names>JD</given-names></name>, and <name name-style="western"><surname>Landman</surname><given-names>AB</given-names></name>, <article-title>Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department: A Mixed-methods Study</article-title>, <source>Acad Emerg Med</source><volume>23</volume> (<year>2016</year>), <fpage>406</fpage>&#8211;<lpage>414</lpage>.<pub-id pub-id-type="pmid">26806310</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/acem.12905</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ponnapalli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Grando</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murcko</surname><given-names>A</given-names></name>, and <name name-style="western"><surname>Wertheim</surname><given-names>P</given-names></name>, <article-title>Systematic Literature Review of Prescription Drug Monitoring Programs</article-title>, <source>AMIA Annu Symp Proc</source><volume>2018</volume> (<year>2018</year>), <fpage>1478</fpage>&#8211;<lpage>1487</lpage>.<pub-id pub-id-type="pmid">30815193</pub-id><pub-id pub-id-type="pmcid">PMC6371270</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Young</surname><given-names>HW</given-names><suffix>2nd</suffix></name>, <name name-style="western"><surname>Tyndall</surname><given-names>JA</given-names></name>, and <name name-style="western"><surname>Cottler</surname><given-names>LB</given-names></name>, <article-title>The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida</article-title>, <source>International journal of emergency medicine</source><volume>10</volume> (<year>2017</year>), <fpage>16</fpage>&#8211;<lpage>16</lpage>.<pub-id pub-id-type="pmid">28421563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12245-017-0140-0</pub-id><pub-id pub-id-type="pmcid">PMC5395509</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Salinas</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Susalka</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Burton</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Roepke</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Evanyo</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Biondi</surname><given-names>D</given-names></name>, and <name name-style="western"><surname>Nicholson</surname><given-names>S</given-names></name>, <article-title>Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: a national multifaceted assessment of physicians, pharmacists, and their patients</article-title>, <source>J Opioid Manag</source><volume>8</volume> (<year>2012</year>), <fpage>273</fpage>&#8211;<lpage>284</lpage>.<pub-id pub-id-type="pmid">23247904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2012.0127</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yanni</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Weaver</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Morgan</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Harrington</surname><given-names>SE</given-names></name>, and <name name-style="western"><surname>Ketchum</surname><given-names>JM</given-names></name>, <article-title>Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic</article-title>, <source>J Opioid Manag</source><volume>4</volume> (<year>2008</year>), <fpage>201</fpage>&#8211;<lpage>211</lpage>.<pub-id pub-id-type="pmid">18837203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2008.0026</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sekhon</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Aminjavahery</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>CN</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Roswarski</surname><given-names>MJ</given-names></name>, and <name name-style="western"><surname>Robinette</surname><given-names>C</given-names></name>, <article-title>Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC)</article-title>, <source>Pain Med</source><volume>14</volume> (<year>2013</year>), <fpage>1548</fpage>&#8211;<lpage>1556</lpage>.<pub-id pub-id-type="pmid">23746149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pme.12164</pub-id></mixed-citation></ref><ref id="R34"><label>[34]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chaudhary</surname><given-names>S</given-names></name> and <name name-style="western"><surname>Compton</surname><given-names>P</given-names></name>, <article-title>Use of risk mitigation practices by family nurse practitioners prescribing opioids for the management of chronic nonmalignant pain</article-title>, <source>Subst Abus</source><volume>38</volume> (<year>2017</year>), <fpage>95</fpage>&#8211;<lpage>104</lpage>.<pub-id pub-id-type="pmid">27897471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08897077.2016.1265038</pub-id></mixed-citation></ref><ref id="R35"><label>[35]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jamison</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Sheehan</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Scanlan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Matthews</surname><given-names>M</given-names></name>, and <name name-style="western"><surname>Ross</surname><given-names>EL</given-names></name>, <article-title>Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers</article-title>, <source>J Opioid Manag</source><volume>10</volume> (<year>2014</year>), <fpage>375</fpage>&#8211;<lpage>382</lpage>.<pub-id pub-id-type="pmid">25531955</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2014.0234</pub-id></mixed-citation></ref><ref id="R36"><label>[36]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Trafton</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Martins</surname><given-names>SB</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vucic</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Balt</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Sintek</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Rosenberg</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>D</given-names></name>, and <name name-style="western"><surname>Goldstein</surname><given-names>MK</given-names></name>, <article-title>Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain</article-title>, <source>Implementation Science</source><volume>5</volume> (<year>2010</year>), <fpage>26</fpage>.<pub-id pub-id-type="pmid">20385018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1748-5908-5-26</pub-id><pub-id pub-id-type="pmcid">PMC2868045</pub-id></mixed-citation></ref><ref id="R37"><label>[37]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Satterwhite</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Knight</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Miaskowski</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Ceasar</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zamora</surname><given-names>K</given-names></name>, and <name name-style="western"><surname>Kushel</surname><given-names>M</given-names></name>, <article-title>Sources and Impact of Time Pressure on Opioid Management in the Safety-Net</article-title>, <source>J Am Board Fam Med</source><volume>32</volume> (<year>2019</year>), <fpage>375</fpage>&#8211;<lpage>382</lpage>.<pub-id pub-id-type="pmid">31068401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3122/jabfm.2019.03.180306</pub-id><pub-id pub-id-type="pmcid">PMC6988512</pub-id></mixed-citation></ref><ref id="R38"><label>[38]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>McCalmont</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>RM</given-names></name>, and <name name-style="western"><surname>Friend</surname><given-names>R</given-names></name>, <article-title>Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing?</article-title>, <source>J Opioid Manag</source><volume>14</volume> (<year>2018</year>), <fpage>103</fpage>&#8211;<lpage>116</lpage>.<pub-id pub-id-type="pmid">29733096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5055/jom.2018.0437</pub-id></mixed-citation></ref><ref id="R39"><label>[39]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chen</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Hom</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Richman</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Asch</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Podchiyska</surname><given-names>T</given-names></name>, and <name name-style="western"><surname>Johansen</surname><given-names>NA</given-names></name>, <article-title>Effect of opioid prescribing guidelines in primary care</article-title>, <source>Medicine (Baltimore)</source><volume>95</volume> (<year>2016</year>), <fpage>e4760</fpage>.<pub-id pub-id-type="pmid">27583928</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000004760</pub-id><pub-id pub-id-type="pmcid">PMC5008612</pub-id></mixed-citation></ref><ref id="R40"><label>[40]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kavukcu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Akdeniz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Avci</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Altug</surname><given-names>M</given-names></name>, and <name name-style="western"><surname>Oner</surname><given-names>M</given-names></name>, <article-title>Chronic noncancer pain management in primary care: family medicine physicians&#8217; risk assessment of opioid misuse</article-title>, <source>Postgrad Med</source><volume>127</volume> (<year>2015</year>), <fpage>22</fpage>&#8211;<lpage>26</lpage>.<pub-id pub-id-type="pmid">25539797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00325481.2015.993572</pub-id></mixed-citation></ref><ref id="R41"><label>[41]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Harle</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Bauer</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Hoang</surname><given-names>HQ</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Hurley</surname><given-names>RW</given-names></name>, and <name name-style="western"><surname>Fillingim</surname><given-names>RB</given-names></name>, <article-title>Decision support for chronic pain care: how do primary care physicians decide when to prescribe opioids? a qualitative study</article-title>, <source>BMC Family Practice</source><volume>16</volume> (<year>2015</year>), <fpage>48</fpage>.<pub-id pub-id-type="pmid">25884340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12875-015-0264-3</pub-id><pub-id pub-id-type="pmcid">PMC4399157</pub-id></mixed-citation></ref><ref id="R42"><label>[42]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Setnik</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Roland</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Sommerville</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Pixton</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Berke</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Calkins</surname><given-names>A</given-names></name>, and <name name-style="western"><surname>Goli</surname><given-names>V</given-names></name>, <article-title>A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain</article-title>, <source>J Pain Res</source><volume>8</volume> (<year>2015</year>), <fpage>361</fpage>&#8211;<lpage>373</lpage>.<pub-id pub-id-type="pmid">26185467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/JPR.S82396</pub-id><pub-id pub-id-type="pmcid">PMC4501355</pub-id></mixed-citation></ref><ref id="R43"><label>[43]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tong</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Hochheimer</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Sabo</surname><given-names>RT</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rozman</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Kashiri</surname><given-names>PL</given-names></name>, and <name name-style="western"><surname>Krist</surname><given-names>AH</given-names></name>, <article-title>Chronic Opioid Prescribing in Primary Care: Factors and Perspectives</article-title>, <source>The Annals of Family Medicine</source><volume>17</volume> (<year>2019</year>), <fpage>200</fpage>.<pub-id pub-id-type="pmid">31085523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1370/afm.2357</pub-id><pub-id pub-id-type="pmcid">PMC6827634</pub-id></mixed-citation></ref><ref id="R44"><label>[44]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kennedy</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Binswanger</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Mueller</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Levy</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Matlock</surname><given-names>DD</given-names></name>, <name name-style="western"><surname>Calcaterra</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Koester</surname><given-names>S</given-names></name>, and <name name-style="western"><surname>Frank</surname><given-names>JW</given-names></name>, <article-title>&#8220;Those Conversations in My Experience Don&#8217;t Go Well&#8221;: A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications</article-title>, <source>Pain Med</source><volume>19</volume> (<year>2018</year>), <fpage>2201</fpage>&#8211;<lpage>2211</lpage>.<pub-id pub-id-type="pmid">29126138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pnx276</pub-id><pub-id pub-id-type="pmcid">PMC6454789</pub-id></mixed-citation></ref><ref id="R45"><label>[45]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Williams</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Nunes</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Bisaga</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>FR</given-names></name>, and <name name-style="western"><surname>Olfson</surname><given-names>M</given-names></name>, <article-title>Development of a Cascade of Care for responding to the opioid epidemic</article-title>, <source>Am J Drug Alcohol Abuse</source><volume>45</volume> (<year>2019</year>), <fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">30675818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00952990.2018.1546862</pub-id><pub-id pub-id-type="pmcid">PMC6404749</pub-id></mixed-citation></ref><ref id="R46"><label>[46]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weller</surname><given-names>LM</given-names></name>, <article-title>Development and implementation of a primary care clinic workflow protocol to meet opioid prescribing guidelines</article-title>, <source>J Am Assoc Nurse Pract</source> (<year>2020</year>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JXX.0000000000000487</pub-id><pub-id pub-id-type="pmid">32804807</pub-id></mixed-citation></ref><ref id="R47"><label>[47]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Anderson</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Zlateva</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Khatri</surname><given-names>K</given-names></name>, and <name name-style="western"><surname>Ciaburri</surname><given-names>N</given-names></name>, <article-title>Using health information technology to improve adherence to opioid prescribing guidelines in primary care</article-title>, <source>Clin J Pain</source><volume>31</volume> (<year>2015</year>), <fpage>573</fpage>&#8211;<lpage>579</lpage>.<pub-id pub-id-type="pmid">25411860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AJP.0000000000000177</pub-id><pub-id pub-id-type="pmcid">PMC4422375</pub-id></mixed-citation></ref><ref id="R48"><label>[48]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Allen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sproule</surname><given-names>B</given-names></name>, <name name-style="western"><surname>MacDougall</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Furlan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Borg Debono</surname><given-names>V</given-names></name>, and <name name-style="western"><surname>Buckley</surname><given-names>N</given-names></name>, <article-title>Identifying appropriate outcomes to help evaluate the impact of the Canadian Guideline for Safe and Effective Use of Opioids for Non-Cancer Pain</article-title>, <source>BMC Anesthesiol</source><volume>20</volume> (<year>2020</year>), <fpage>6</fpage>.<pub-id pub-id-type="pmid">31910806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12871-020-0930-4</pub-id><pub-id pub-id-type="pmcid">PMC6945645</pub-id></mixed-citation></ref><ref id="R49"><label>[49]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Roland</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Lake</surname><given-names>J</given-names></name>, and <name name-style="western"><surname>Oderda</surname><given-names>GM</given-names></name>, <article-title>Prevalence of Prescription Opioid Misuse/Abuse as Determined by International Classification of Diseases Codes: A Systematic Review</article-title>, <source>J Pain Palliat Care Pharmacother</source><volume>30</volume> (<year>2016</year>), <fpage>258</fpage>&#8211;<lpage>268</lpage>.<pub-id pub-id-type="pmid">27802072</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15360288.2016.1231739</pub-id></mixed-citation></ref><ref id="R50"><label>[50]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Karmali</surname><given-names>RN</given-names></name>, <name name-style="western"><surname>Bush</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Raman</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>CI</given-names></name>, <name name-style="western"><surname>Skinner</surname><given-names>AC</given-names></name>, and <name name-style="western"><surname>Roberts</surname><given-names>AW</given-names></name>, <article-title>Long-term opioid therapy definitions and predictors: A systematic review</article-title>, <source>Pharmacoepidemiol Drug Saf</source><volume>29</volume> (<year>2020</year>), <fpage>252</fpage>&#8211;<lpage>269</lpage>.<pub-id pub-id-type="pmid">31851773</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pds.4929</pub-id><pub-id pub-id-type="pmcid">PMC7058495</pub-id></mixed-citation></ref><ref id="R51"><label>[51]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Pergolizzi</surname><given-names>JV</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Gharibo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Passik</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Labhsetwar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>R</given-names><suffix>Jr.</suffix></name>, <name name-style="western"><surname>Pergolizzi</surname><given-names>JS</given-names></name>, and <name name-style="western"><surname>M&#252;ller-Schwefe</surname><given-names>G</given-names></name>, <article-title>Dynamic risk factors in the misuse of opioid analgesics</article-title>, <source>J Psychosom Res</source><volume>72</volume> (<year>2012</year>), <fpage>443</fpage>&#8211;<lpage>451</lpage>.<pub-id pub-id-type="pmid">22656441</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpsychores.2012.02.009</pub-id></mixed-citation></ref><ref id="R52"><label>[52]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Clark</surname><given-names>MR</given-names></name>, <name name-style="western"><surname>Hurley</surname><given-names>RW</given-names></name>, and <name name-style="western"><surname>Adams</surname><given-names>MCB</given-names></name>, <article-title>Reassessing the Validity of the Opioid Risk Tool in a Tertiary Academic Pain Management Center Population</article-title>, <source>Pain Med</source> (<year>2018</year>).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pnx332</pub-id><pub-id pub-id-type="pmcid">PMC7191882</pub-id><pub-id pub-id-type="pmid">29408996</pub-id></mixed-citation></ref><ref id="R53"><label>[53]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Haller</surname><given-names>IV</given-names></name>, <name name-style="western"><surname>Renier</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Juusola</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hitz</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Steffen</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Asmus</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Craig</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Mardekian</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Masters</surname><given-names>ET</given-names></name>, and <name name-style="western"><surname>Elliott</surname><given-names>TE</given-names></name>, <article-title>Enhancing Risk Assessment in Patients Receiving Chronic Opioid Analgesic Therapy Using Natural Language Processing</article-title>, <source>Pain Med</source><volume>18</volume> (<year>2017</year>), <fpage>1952</fpage>&#8211;<lpage>1960</lpage>.<pub-id pub-id-type="pmid">28034982</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pm/pnw283</pub-id></mixed-citation></ref><ref id="R54"><label>[54]</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ducharme</surname><given-names>J</given-names></name> and <name name-style="western"><surname>Moore</surname><given-names>S</given-names></name>, <article-title>Opioid Use Disorder Assessment Tools and Drug Screening</article-title>, <source>Missouri medicine</source><volume>116</volume> (<year>2019</year>), <fpage>318</fpage>&#8211;<lpage>324</lpage>.<pub-id pub-id-type="pmid">31527982</pub-id><pub-id pub-id-type="pmcid">PMC6699803</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1" orientation="portrait"><label>Figure-1.</label><caption><p id="P12">Systems view - Interplays between clinical tools, processes, and information systems in the primary care setting. Grey boxes: outcomes; Yellow boxes: clinical decisions; Information systems: EHR, PDMP, PreManage (a collective ambulatory platform that can receive data from Emergency Department Information Exchange (EDIE)), State Health Authority; Clinical decision tools/test: CDS (Clinical Decision Support); risk assesment tools, UDS (Urine Drug Screening)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-1890822-f0001.jpg"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table -1.</label><caption><p id="P13">Summary of literature review along the different dimensions of the selected frameworks</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">DIMENSIONS</th><th align="left" valign="top" rowspan="1" colspan="1">SYSTEM COMPONENT</th><th align="left" valign="top" rowspan="1" colspan="1">SUMMARY</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">EXTERNAL POLICIES<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup>/<break/>KNOWLEDGE<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup>/<break/>EVIDENCE<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup>/</td><td align="left" valign="top" rowspan="1" colspan="1">CDC guidelines</td><td align="left" valign="top" rowspan="1" colspan="1">It is important to note that most recommendations in the guidelines are supported by very weak evidence, type 3 or type 4. Though the intent of the CDC guidelines was not to be used as rigid rules, the recommended ceiling dose of 90 MME has been used as a hard limit by some payers and providers, leading to unintended con-sequences. Patients have been discharged from practice or abruptly tapered without appropriate weaning or OUD treatment.[<xref rid="R9" ref-type="bibr">9</xref>] Further, the guidelines do not specify how to taper safely. As far as identifying and predicting misuse and diagnosing OUD is concerned, no widely used risk assessment tool accurately predicts or identifies misuse, and applying DSM-V criteria to CNCP patients on LTOT has proven to be difficult.[<xref rid="R9" ref-type="bibr">9</xref>; <xref rid="R16" ref-type="bibr">16</xref>].</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CLINICAL<break/>CONTENT<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">EHR</td><td align="left" valign="top" rowspan="1" colspan="1">Many factors seem to influence the quality of patient-specific risk data in the EHR, influencing the risk assessment process. Stigma associated with opioid addiction may have led to variable and inconsistent documentation of opioid misuse and abuse in the EHR.[<xref rid="R17" ref-type="bibr">17</xref>] There are variations in the use and documentation of screening tools in the EHR.[<xref rid="R18" ref-type="bibr">18</xref>] Aberrant drug-related behaviors, used as indicators of misuse, are inconsistently and unsystematically documented in the EHR.[<xref rid="R19" ref-type="bibr">19</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">INTERNAL POLICIES, PROCEDURES and CULTURES<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup>/<break/>BEHAVIOR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup>/<break/>FACILITATION<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">Organizational policies</td><td align="left" valign="top" rowspan="1" colspan="1">Internal policies play significant roles in adherence to risk assessment tasks. Standardized opioid prescribing and monitoring policies improve adherence to guidelines.[<xref rid="R20" ref-type="bibr">20</xref>&#8211;<xref rid="R22" ref-type="bibr">22</xref>] Random urine drug tests and mandatory PDMP reviews effectively detect high-risk behavior and addiction even in low-risk patients and decrease monthly dispense of opioids and benzodiazepines, respectively.[<xref rid="R23" ref-type="bibr">23</xref>; <xref rid="R24" ref-type="bibr">24</xref>] Development of a risk-assessment algorithm and risk-stratified monitoring guidelines also improve adherence to guidelines.[<xref rid="R20" ref-type="bibr">20</xref>] Further, non-collaborative opioid taper increases patient risk.[<xref rid="R9" ref-type="bibr">9</xref>] Organizational culture that embraces educational interventions and audit and feedback processes increases guideline adherence.[<xref rid="R25" ref-type="bibr">25</xref>; <xref rid="R26" ref-type="bibr">26</xref>] &#8220;Academic detailing&#8221; models and a team-based approach to care with physician assistant care managers increase adherence to guidelines.[<xref rid="R20" ref-type="bibr">20</xref>; <xref rid="R27" ref-type="bibr">27</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HUMAN-COMPUTER</td><td align="left" valign="top" rowspan="1" colspan="1">EHR</td><td align="left" valign="top" rowspan="1" colspan="1">A patient registry with regular dissemination of reports to PCPs increases adherence to guidelines.[<xref rid="R20" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">INTERFACE<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup>/<break/>BEHAVIOR<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup><break/>FACILITATION<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup>/</td><td align="left" valign="top" rowspan="1" colspan="1">PDMP</td><td align="left" valign="top" rowspan="1" colspan="1">Difficulty accessing the PDMP and acquiring patient medication history information within the PDMP, due to non-intuitive display, are significant barriers to its use.[<xref rid="R28" ref-type="bibr">28</xref>] Also, the lack of standards for PDMP integration into EHRs results in poor usability and decreased usage.[<xref rid="R29" ref-type="bibr">29</xref>] Increased interoperability and good human-computer interfaces can facilitate risk assessment and improve adherence.</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">PEOPLE<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup>/<break/>KNOWLEDGE<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup>/<break/>CONTEXT<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">PCPs</td><td align="left" valign="top" rowspan="1" colspan="1">Physicians underutilize Urine Drug Screens (UDS), written Opioid Use Agreements (OUA), and Prescription Drug Monitoring Programs (PDMP).[<xref rid="R30" ref-type="bibr">30</xref>&#8211;<xref rid="R34" ref-type="bibr">34</xref>] Variabilities exist among providers in the interpretation of opioid risks.[<xref rid="R31" ref-type="bibr">31</xref>] Some PCPs are reluctant to manage prescription opioids for CNCP patients.[<xref rid="R35" ref-type="bibr">35</xref>] Providers find the treatment of chronic pain challenging and desire additional training and referral support. [<xref rid="R18" ref-type="bibr">18</xref>] Lack of time and training are significant barriers to guideline adherence.[<xref rid="R18" ref-type="bibr">18</xref>; <xref rid="R36" ref-type="bibr">36</xref>; <xref rid="R37" ref-type="bibr">37</xref>] Educating providers leads to improved knowledge and confidence to manage COT patients per guidelines and increased screening practices.[<xref rid="R38" ref-type="bibr">38</xref>&#8211;<xref rid="R40" ref-type="bibr">40</xref>] A patient&#8217;s risk level is determined based on the level of trust and history of knowing the patient.[<xref rid="R41" ref-type="bibr">41</xref>; <xref rid="R42" ref-type="bibr">42</xref>] Further, a provider&#8217;s ability to taper is influenced by medical contraindications of non-opioid alternatives, difficulty justifying opioid wean for patients who are stable on chronic opioid use, type of patient&#8217;s insurance coverage, and patient-provider trust.[<xref rid="R9" ref-type="bibr">9</xref>; <xref rid="R43" ref-type="bibr">43</xref>; <xref rid="R44" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patients</td><td align="left" valign="top" rowspan="1" colspan="1">Patient preference for tapering influences the provider&#8217;s ability to taper.[<xref rid="R43" ref-type="bibr">43</xref>] Patients with OUD are often not diagnosed and referred for treatment, partly due to the stigma attached with diagnosis and treatment.[<xref rid="R45" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WORKFLOW and COMMUNICATION<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup>/<break/>FACILITATION<sup><xref rid="TFN4" ref-type="table-fn">c</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">Workflow</td><td align="left" valign="top" rowspan="1" colspan="1">Implementing workflow protocol improves adherence to best practices[<xref rid="R46" ref-type="bibr">46</xref>]; EHR innovations, like the <italic toggle="yes">EHR dashboard</italic>, facilitate communication and increases guideline adherence[<xref rid="R20" ref-type="bibr">20</xref>; <xref rid="R47" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CONTEXT<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">Practice type</td><td align="left" valign="top" rowspan="1" colspan="1">lack of availability of comprehensive, multimodal pain care may limit guideline adherence[<xref rid="R9" ref-type="bibr">9</xref>]</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">MEASURING AND MONITORING<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></td><td align="left" valign="top" rowspan="1" colspan="1">Quality measures</td><td align="left" valign="top" rowspan="1" colspan="1">There is a need for clinically relevant outcome measures.[<xref rid="R48" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Data</td><td align="left" valign="top" rowspan="1" colspan="1">Measuring outcomes is challenging due to inconsistent use of terminologies and ICD codes for problem opioid use and varying definition of LTOT, with 41 unique variations across 34 studies.[<xref rid="R17" ref-type="bibr">17</xref>; <xref rid="R49" ref-type="bibr">49</xref>; <xref rid="R50" ref-type="bibr">50</xref>]</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P14">Note:</p></fn><fn id="TFN2"><label>a</label><p id="P15">&#8211; dimension from ST-HIT framework;</p></fn><fn id="TFN3"><label>b</label><p id="P16">&#8211; dimensions from Cabana framework;</p></fn><fn id="TFN4"><label>c</label><p id="P17">&#8211; dimension from PARIHS framework</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>